The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
New offshoring locations
Germany
115 jobs Number of planned job losses
Announcement Date
26 April 2005
Employment effect (start)
Foreseen end date
Description
According to Andreas Rummelt, CEO of Sandoz, the world leader in developing, manufacturing and marketing generic pharmaceuticals and part of the Swiss Novartis Group, the global headquarters of the company currently located in Vienna is planned to be transferred to Holzkirchen, Germany. The main reason for this choice is the proximity to major operational sites of the company in Bavaria and in Kundl, Tyrol (Austria). As a consequence, 115 employees working in the administration of the headquarters in Vienna stand to lose their jobs. However, the departure of the Sandoz headquarters from Vienna will have no impact on the activities of the pharma research centre in Vienna, which employs some 50 workers.
Sources
26 April 2005: Der Standard
Citation
Eurofound (2005), Sandoz, Offshoring/Delocalisation in Austria, factsheet number 61491, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/61491.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
